Catheter Precision, Inc. (VTAK) Financial Statements (2026 and earlier)

Company Profile

Business Address 1670 HIGHWAY 160 WEST
FORT MILL, SC 29708
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments882,8733,60015,85915,04523,906
Cash and cash equivalent882,8733,60015,85915,04523,906
Receivables15570137 21238
Inventory, net of allowances, customer advances and progress billings863344 9862,218
Inventory863344 9862,218
Other undisclosed current assets613163809771,0371,258
Total current assets:3903,2924,16116,83617,08927,620
Noncurrent Assets
Operating lease, right-of-use asset162105179 2,1102,484
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization649170 1,8093,211
Intangible asset, including goodwill, after accumulated amortization15,23624,27426,318   
Goodwill      
Intangible asset, excluding goodwill, after accumulated amortization15,23624,27426,318   
Other noncurrent assets888 36123
Total noncurrent assets:15,47024,47826,575 3,9555,818
TOTAL ASSETS:15,86027,77030,73616,83621,04433,438
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1891,7782,1977,5765,1074,919
Accounts payable1,49223046492988571
Accrued liabilities1,6971,5481,7337,4844,1194,348
Deferred revenue     1,801
Debt298177184  421
Other undisclosed current liabilities42013091 283621
Total current liabilities:3,9072,0852,4727,5765,3907,762
Noncurrent Liabilities
Long-term debt and lease obligation  1,500  1,9812,264
Long-term debt, excluding current maturities  1,500    
Liabilities, other than long-term debt1,4323,15497  686
Deferred revenue      686
Deferred income tax liabilities1,3313,141    
Operating lease, liability1011397 1,9812,264
Other undisclosed noncurrent liabilities3,8709,2746,974 (1,981)1,579
Total noncurrent liabilities:5,30213,9287,071 1,9814,529
Total liabilities:9,20916,0139,5437,5767,37112,291
Equity
Equity, attributable to parent7,05411,75721,1939,26013,67321,147
Common stock   1 87
Additional paid in capital316,589304,109296,901214,397191,937174,342
Accumulated deficit(309,535)(292,352)(275,709)(205,137)(178,272)(153,202)
Equity, attributable to noncontrolling interest(403)     
Total equity:6,65111,75721,1939,26013,67321,147
TOTAL LIABILITIES AND EQUITY:15,86027,77030,73616,83621,04433,438

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues81942044214224,405
Cost of revenue(63)(42)(30)(161)(1,560)(5,482)
Cost of product and service sold(63)(42) (161)(1,560)(5,482)
Gross profit:756378412(147)(1,538)(1,077)
Operating expenses(21,899)(11,621)(78,531)(26,814)(27,728)(34,982)
Operating loss:(21,143)(11,243)(78,119)(26,961)(29,266)(36,059)
Nonoperating income (expense)1,638(2,259)7,547992,00921
Investment income, nonoperating3481   129
Other nonoperating income (expense)(2)(10)(8)99(14) 
Interest and debt expense (3,260)   2,023(108)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(22,765)(13,502)(70,572)(26,862)(25,234)(36,146)
Other undisclosed income (loss) from continuing operations before income taxes3,260   (2,023)108
Loss from continuing operations before income taxes:(19,505)(13,502)(70,572)(26,862)(27,257)(36,038)
Income tax expense (benefit)1,810(3,141) (3)(4)(7)
Loss from continuing operations:(17,695)(16,643)(70,572)(26,865)(27,261)(36,045)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(25,070)(36,045)
Income from discontinued operations     2,191 
Net loss:(17,695)(16,643)(70,572)(26,865)(25,070)(36,045)
Net income attributable to noncontrolling interest512     
Net loss attributable to parent:(17,183)(16,643)(70,572)(26,865)(25,070)(36,045)
Other undisclosed net loss available to common stockholders, basic (5,158)    
Net loss available to common stockholders, basic:(17,183)(21,801)(70,572)(26,865)(25,070)(36,045)
Other undisclosed net loss available to common stockholders, diluted   (800)   
Net loss available to common stockholders, diluted:(17,183)(21,801)(71,372)(26,865)(25,070)(36,045)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(17,695)(16,643)(70,572)(26,865)(25,070)(36,045)
Other comprehensive loss      (26)
Comprehensive loss:(17,695)(16,643)(70,572)(26,865)(25,070)(36,071)
Comprehensive income, net of tax, attributable to noncontrolling interest512     
Comprehensive loss, net of tax, attributable to parent:(17,183)(16,643)(70,572)(26,865)(25,070)(36,071)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: